| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 6.94e-05 | 14 | 18 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.08e-03 | 230 | 18 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.26e-03 | 548 | 18 | 4 | GO:0005543 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 1.04e-04 | 293 | 18 | 4 | GO:0048167 | |
| GeneOntologyBiologicalProcess | glutamate secretion | 5.50e-04 | 40 | 18 | 2 | GO:0014047 | |
| GeneOntologyBiologicalProcess | amino acid transport | 6.11e-04 | 195 | 18 | 3 | GO:0006865 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 7.27e-04 | 207 | 18 | 3 | GO:1990138 | |
| GeneOntologyBiologicalProcess | positive regulation of cell growth | 7.90e-04 | 213 | 18 | 3 | GO:0030307 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 9.71e-04 | 931 | 18 | 5 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 9.71e-04 | 931 | 18 | 5 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 1.01e-03 | 939 | 18 | 5 | GO:0099537 | |
| GeneOntologyBiologicalProcess | positive regulation of axon extension | 1.04e-03 | 55 | 18 | 2 | GO:0045773 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 1.09e-03 | 238 | 18 | 3 | GO:0048639 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 1.20e-03 | 976 | 18 | 5 | GO:0099536 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 2.09e-03 | 299 | 18 | 3 | GO:0060560 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 2.13e-03 | 301 | 18 | 3 | GO:0048588 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 2.26e-03 | 663 | 18 | 4 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 2.27e-03 | 664 | 18 | 4 | GO:0099177 | |
| GeneOntologyBiologicalProcess | acidic amino acid transport | 2.40e-03 | 84 | 18 | 2 | GO:0015800 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 2.69e-03 | 89 | 18 | 2 | GO:1901880 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 2.88e-06 | 276 | 18 | 5 | GO:0000775 | |
| GeneOntologyCellularComponent | chromosomal region | 2.23e-05 | 421 | 18 | 5 | GO:0098687 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 4.34e-05 | 817 | 18 | 6 | GO:0098978 | |
| GeneOntologyCellularComponent | axon | 7.04e-05 | 891 | 18 | 6 | GO:0030424 | |
| GeneOntologyCellularComponent | condensed chromosome | 1.19e-04 | 307 | 18 | 4 | GO:0000793 | |
| GeneOntologyCellularComponent | postsynapse | 1.47e-04 | 1018 | 18 | 6 | GO:0098794 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 3.42e-04 | 32 | 18 | 2 | GO:0005721 | |
| GeneOntologyCellularComponent | kinetochore | 4.73e-04 | 181 | 18 | 3 | GO:0000776 | |
| GeneOntologyCellularComponent | neuronal cell body | 5.58e-04 | 835 | 18 | 5 | GO:0043025 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 5.71e-04 | 193 | 18 | 3 | GO:0000779 | |
| GeneOntologyCellularComponent | cell body | 9.05e-04 | 929 | 18 | 5 | GO:0044297 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.40e-03 | 85 | 18 | 2 | GO:0000118 | |
| GeneOntologyCellularComponent | supramolecular fiber | 2.62e-03 | 1179 | 18 | 5 | GO:0099512 | |
| GeneOntologyCellularComponent | main axon | 2.62e-03 | 89 | 18 | 2 | GO:0044304 | |
| GeneOntologyCellularComponent | supramolecular polymer | 2.69e-03 | 1187 | 18 | 5 | GO:0099081 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.04e-03 | 96 | 18 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 3.12e-03 | 1228 | 18 | 5 | GO:0036477 | |
| GeneOntologyCellularComponent | heterochromatin | 3.36e-03 | 101 | 18 | 2 | GO:0000792 | |
| GeneOntologyCellularComponent | cell cortex | 3.71e-03 | 371 | 18 | 3 | GO:0005938 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 5.42e-03 | 129 | 18 | 2 | GO:0030863 | |
| GeneOntologyCellularComponent | ATPase complex | 5.42e-03 | 129 | 18 | 2 | GO:1904949 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 6.42e-03 | 899 | 18 | 4 | GO:0099513 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 7.33e-03 | 934 | 18 | 4 | GO:0048471 | |
| GeneOntologyCellularComponent | brush border | 7.45e-03 | 152 | 18 | 2 | GO:0005903 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 7.73e-03 | 155 | 18 | 2 | GO:0098685 | |
| MousePheno | impaired social transmission of food preference | 5.88e-05 | 11 | 15 | 2 | MP:0002969 | |
| MousePheno | impaired discrimination learning | 9.71e-05 | 14 | 15 | 2 | MP:0012296 | |
| Domain | Ion_trans_dom | 4.73e-03 | 114 | 17 | 2 | IPR005821 | |
| Domain | Ion_trans | 4.73e-03 | 114 | 17 | 2 | PF00520 | |
| Domain | Znf_FYVE_PHD | 7.74e-03 | 147 | 17 | 2 | IPR011011 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 7.58e-08 | 219 | 18 | 5 | 31353912 | |
| Pubmed | Cdx2 regulates endo-lysosomal function and epithelial cell polarity. | 6.29e-07 | 33 | 18 | 3 | 20551175 | |
| Pubmed | 1.52e-06 | 4 | 18 | 2 | 11163362 | ||
| Pubmed | 3.79e-06 | 6 | 18 | 2 | 15975910 | ||
| Pubmed | Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. | 3.79e-06 | 6 | 18 | 2 | 17416589 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 8.80e-06 | 1024 | 18 | 6 | 24711643 | |
| Pubmed | 9.09e-06 | 9 | 18 | 2 | 11290752 | ||
| Pubmed | 9.09e-06 | 9 | 18 | 2 | 29059194 | ||
| Pubmed | USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. | 1.14e-05 | 10 | 18 | 2 | 36653359 | |
| Pubmed | 1.52e-05 | 645 | 18 | 5 | 25281560 | ||
| Pubmed | 1.97e-05 | 13 | 18 | 2 | 18796539 | ||
| Pubmed | 1.97e-05 | 13 | 18 | 2 | 29222402 | ||
| Pubmed | Cochlear hair cell innervation is dependent on a modulatory function of Semaphorin-3A. | 2.29e-05 | 14 | 18 | 2 | 36284453 | |
| Pubmed | 2.29e-05 | 14 | 18 | 2 | 21875947 | ||
| Pubmed | 2.30e-05 | 334 | 18 | 4 | 30425250 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.64e-05 | 724 | 18 | 5 | 36232890 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.38e-05 | 394 | 18 | 4 | 27248496 | |
| Pubmed | The small GTPase Rac1 regulates auditory hair cell morphogenesis. | 6.36e-05 | 23 | 18 | 2 | 20016102 | |
| Pubmed | 9.48e-05 | 481 | 18 | 4 | 28190767 | ||
| Pubmed | 9.49e-05 | 28 | 18 | 2 | 27611684 | ||
| Pubmed | Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. | 1.09e-04 | 182 | 18 | 3 | 26527279 | |
| Pubmed | 1.09e-04 | 30 | 18 | 2 | 19054571 | ||
| Pubmed | 1.24e-04 | 32 | 18 | 2 | 14973295 | ||
| Pubmed | 1.41e-04 | 34 | 18 | 2 | 23926254 | ||
| Pubmed | 1.52e-04 | 204 | 18 | 3 | 25659154 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.76e-04 | 38 | 18 | 2 | 30786075 | |
| Pubmed | 1.76e-04 | 38 | 18 | 2 | 31597102 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 2.60e-04 | 626 | 18 | 4 | 33644029 | |
| Pubmed | 3.18e-04 | 660 | 18 | 4 | 32780723 | ||
| Pubmed | 3.41e-04 | 1247 | 18 | 5 | 27684187 | ||
| Pubmed | RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma. | 4.70e-04 | 62 | 18 | 2 | 35568845 | |
| Pubmed | 4.85e-04 | 63 | 18 | 2 | 37052853 | ||
| Interaction | WDR76 interactions | 1.69e-05 | 383 | 18 | 5 | int:WDR76 | |
| Interaction | L3MBTL2 interactions | 4.54e-05 | 231 | 18 | 4 | int:L3MBTL2 | |
| Interaction | FURIN interactions | 6.66e-05 | 255 | 18 | 4 | int:FURIN | |
| Interaction | LRRC49 interactions | 1.03e-04 | 104 | 18 | 3 | int:LRRC49 | |
| Interaction | ZFYVE16 interactions | 1.03e-04 | 104 | 18 | 3 | int:ZFYVE16 | |
| Interaction | PCDH19 interactions | 1.72e-04 | 22 | 18 | 2 | int:PCDH19 | |
| Interaction | TRPC4 interactions | 1.89e-04 | 23 | 18 | 2 | int:TRPC4 | |
| Interaction | ZNF333 interactions | 2.06e-04 | 24 | 18 | 2 | int:ZNF333 | |
| Interaction | TRPC5 interactions | 2.06e-04 | 24 | 18 | 2 | int:TRPC5 | |
| Interaction | CCDC8 interactions | 2.17e-04 | 656 | 18 | 5 | int:CCDC8 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.23e-03 | 181 | 13 | 2 | 694 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN | 9.26e-06 | 200 | 18 | 4 | M7196 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 4.77e-05 | 304 | 18 | 4 | M39113 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | 5.28e-05 | 312 | 18 | 4 | M39161 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.96e-09 | 180 | 18 | 5 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.96e-09 | 180 | 18 | 5 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.96e-09 | 180 | 18 | 5 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.00e-07 | 190 | 18 | 4 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.78e-07 | 194 | 18 | 4 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 1.02e-06 | 196 | 18 | 4 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.06e-06 | 198 | 18 | 4 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-Neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-06 | 200 | 18 | 4 | b9538eb33ac86384e7e289a5a82fac4d56a7b9c2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-06 | 200 | 18 | 4 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 3.73e-05 | 164 | 18 | 3 | 7766900740f67dbbe3c4d90fbfdcc1665cee6515 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 168 | 18 | 3 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-05 | 169 | 18 | 3 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-05 | 171 | 18 | 3 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-05 | 171 | 18 | 3 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-05 | 172 | 18 | 3 | 107417cfab7775bc1f80807115047abfb50b7a7e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-05 | 174 | 18 | 3 | c2f8c59fca5f1ff6ffa6dc8cfce62da4b19fe9b3 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-05 | 174 | 18 | 3 | 84024c04b0ce9f7068677d2d99ede56882b7dbd2 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 174 | 18 | 3 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 174 | 18 | 3 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-05 | 174 | 18 | 3 | 0227fea1678baa9168bd47c3b4aacb2592bb5867 | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.60e-05 | 176 | 18 | 3 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.92e-05 | 180 | 18 | 3 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 182 | 18 | 3 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 182 | 18 | 3 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-05 | 184 | 18 | 3 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.33e-05 | 185 | 18 | 3 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 186 | 18 | 3 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-05 | 186 | 18 | 3 | 18fd311252299d6d30ddb32002ed069056108206 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.51e-05 | 187 | 18 | 3 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.59e-05 | 188 | 18 | 3 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 5.59e-05 | 188 | 18 | 3 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.68e-05 | 189 | 18 | 3 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.77e-05 | 190 | 18 | 3 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.77e-05 | 190 | 18 | 3 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.77e-05 | 190 | 18 | 3 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.77e-05 | 190 | 18 | 3 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.77e-05 | 190 | 18 | 3 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.77e-05 | 190 | 18 | 3 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.86e-05 | 191 | 18 | 3 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.86e-05 | 191 | 18 | 3 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.86e-05 | 191 | 18 | 3 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-05 | 191 | 18 | 3 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 5.86e-05 | 191 | 18 | 3 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.86e-05 | 191 | 18 | 3 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-05 | 191 | 18 | 3 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-05 | 191 | 18 | 3 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.86e-05 | 191 | 18 | 3 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-05 | 191 | 18 | 3 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 5.86e-05 | 191 | 18 | 3 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-05 | 192 | 18 | 3 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-05 | 192 | 18 | 3 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.05e-05 | 193 | 18 | 3 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | LAM-Epithelial-AirwayEpi|Epithelial / Condition, Lineage and Cell class | 6.05e-05 | 193 | 18 | 3 | f2672d2c495ee12c3b7d132452bde581fa5a7856 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-05 | 193 | 18 | 3 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 6.05e-05 | 193 | 18 | 3 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.14e-05 | 194 | 18 | 3 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-immature_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.14e-05 | 194 | 18 | 3 | bf8e78d53802ac758be1c3db833779c26a94e1d5 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.14e-05 | 194 | 18 | 3 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.14e-05 | 194 | 18 | 3 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | E16.5|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-05 | 194 | 18 | 3 | 8a48f596cf1ca43718b9db661305c150e459f8d4 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.24e-05 | 195 | 18 | 3 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | (4)_B_Hypermutation|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.24e-05 | 195 | 18 | 3 | 54d2acaff6be6b5604591bdbd7d769ac3e74f223 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.43e-05 | 197 | 18 | 3 | 41bdea47b9b1f6415a866a515d1535ea942fdede | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.43e-05 | 197 | 18 | 3 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.43e-05 | 197 | 18 | 3 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 197 | 18 | 3 | d9978aaa476b57144b0561f535ff1dd886c7512b | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.52e-05 | 198 | 18 | 3 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.52e-05 | 198 | 18 | 3 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 6.52e-05 | 198 | 18 | 3 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.62e-05 | 199 | 18 | 3 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Influenza_Severe-T/NK_proliferative|Influenza_Severe / Disease group and Cell class | 6.62e-05 | 199 | 18 | 3 | 2508c55f9ffe17b694c70f1283f41ad4a8e83c00 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 6.62e-05 | 199 | 18 | 3 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-Neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.62e-05 | 199 | 18 | 3 | ae575ed7582f2a4218f6cbcbf5f7f0ce7a5bc26b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Neuronal-PNs|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.62e-05 | 199 | 18 | 3 | c8aaf6ebd1cb6f6e59fdffeb81f9a3c921cc592a | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 6.62e-05 | 199 | 18 | 3 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.62e-05 | 199 | 18 | 3 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 6.62e-05 | 199 | 18 | 3 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 6.62e-05 | 199 | 18 | 3 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.72e-05 | 200 | 18 | 3 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | ddac952ad1d46021c2d17d816de9bc31730a0941 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | 04699d1149a143b96d6f292c0d70c4d3e6dfc611 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.72e-05 | 200 | 18 | 3 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-T/NK_proliferative|Influenza_Severe / Disease, condition lineage and cell class | 6.72e-05 | 200 | 18 | 3 | e1c266525ce6b42a4451b6a3b0cabf41ff5e2ee7 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 6.72e-05 | 200 | 18 | 3 | c248233b004f8ef0bab3c65ecfe295887966f2ee | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| Drug | $l^{1}-borane | 5.38e-06 | 44 | 18 | 3 | CID006397184 | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.34e-05 | 191 | 18 | 4 | 4283_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.61e-05 | 200 | 18 | 4 | 3014_DN | |
| Drug | Meglumine [6284-40-8]; Up 200; 20.4uM; HL60; HT_HG-U133A | 1.61e-05 | 200 | 18 | 4 | 3068_UP | |
| Drug | nocodazole | 2.70e-05 | 477 | 18 | 5 | CID000004122 | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.86e-04 | 670 | 16 | 4 | EFO_0006335, EFO_0006336 | |
| Disease | Headache | 5.45e-04 | 64 | 16 | 2 | HP_0002315 | |
| Disease | migraine disorder | 8.75e-04 | 357 | 16 | 3 | MONDO_0005277 | |
| Disease | migraine disorder, Headache | 9.81e-04 | 86 | 16 | 2 | HP_0002315, MONDO_0005277 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 1.07e-03 | 90 | 16 | 2 | DOID:11832 (biomarker_via_orthology) | |
| Disease | upper face morphology measurement | 1.25e-03 | 97 | 16 | 2 | EFO_0010949 | |
| Disease | coronary artery disease, factor VII measurement | 1.63e-03 | 111 | 16 | 2 | EFO_0001645, EFO_0004619 | |
| Disease | response to tenofovir, creatinine clearance measurement | 1.65e-03 | 112 | 16 | 2 | EFO_0007934, EFO_0009279 | |
| Disease | factor VIII measurement, coronary artery disease | 1.68e-03 | 113 | 16 | 2 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 1.74e-03 | 115 | 16 | 2 | EFO_0001645, EFO_0004694 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.83e-03 | 118 | 16 | 2 | EFO_0001645, EFO_0004629 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.02e-03 | 152 | 16 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | fibrinogen measurement, coronary artery disease | 3.10e-03 | 154 | 16 | 2 | EFO_0001645, EFO_0004623 | |
| Disease | prostate cancer (is_marker_for) | 3.17e-03 | 156 | 16 | 2 | DOID:10283 (is_marker_for) | |
| Disease | coronary artery disease | 3.29e-03 | 1194 | 16 | 4 | EFO_0001645 | |
| Disease | complement factor H-related protein 3 measurement | 3.71e-03 | 169 | 16 | 2 | EFO_0600056 | |
| Disease | Colorectal Carcinoma | 5.96e-03 | 702 | 16 | 3 | C0009402 | |
| Disease | opioid dependence | 7.16e-03 | 237 | 16 | 2 | EFO_0005611 | |
| Disease | aortic measurement | 7.99e-03 | 251 | 16 | 2 | EFO_0020865 | |
| Disease | apolipoprotein A 1 measurement | 1.00e-02 | 848 | 16 | 3 | EFO_0004614 | |
| Disease | mitochondrial DNA measurement | 1.33e-02 | 328 | 16 | 2 | EFO_0006312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSNFSNSADDIKSKK | 91 | P45973 | |
| EKNQKSLFKDQKFEA | 346 | Q6P9F0 | |
| FNKQDSKADVSQKAD | 191 | Q96AQ1 | |
| NQKDENKKFSSIFKD | 561 | Q49A88 | |
| DSNLNASRDDKKNKF | 816 | Q14573 | |
| AKKNKKENEDENSSS | 151 | Q9NRZ9 | |
| KDKETKNAANASASK | 2316 | P46821 | |
| AKQDSNNKKDAFSDK | 481 | Q86SP6 | |
| DDSKRKAKSFEGNNN | 531 | O14786 | |
| KKAAKKAAEFNSNLN | 201 | Q8WUB8 | |
| NSKSEFEKENQKGKA | 871 | Q15075 | |
| SKEAKSFFKQNEKEK | 186 | Q9UEE9 | |
| NLNSKKKFGADDKNE | 66 | Q9H2B2 | |
| KNKFNAKQAKQAELD | 441 | Q0VFZ6 | |
| QKAEEDAQFNFNKKK | 176 | Q8NDV3 | |
| KKFDDFQKDLKANES | 1131 | Q13813 | |
| SDSEGNSKDKKKNFS | 781 | Q9UBN4 | |
| NNNKDTKQKAGKLSF | 626 | Q9UM54 |